Rubella immunity levels in the United States population: Has the threshold of viral elimination been reached?

Clinical Infectious Diseases

Volumn 43, Issue SUPPL. 3, 2006, Pages

  Hyde, Terri B ^a   Kruszon Moran, Deanna ^b   McQuillan, Geraldine M ^b   Cossen, Cynthia ^c   Forghani, Bagher ^c   Reef, Susan E ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^c VIRAL AND RICKETTSIAL DISEASE LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; RUBELLA ANTIBODY; RUBELLA VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; ENZYME IMMUNOASSAY; ETHNOLOGY; FEMALE; HEALTH SURVEY; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RUBELLA; SEROPREVALENCE; SEX DIFFERENCE; UNITED STATES; VACCINATION; VIRUS IMMUNITY;

ADOLESCENT; ADULT; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; RUBELLA; RUBELLA VACCINE; RUBELLA VIRUS; SEROEPIDEMIOLOGIC STUDIES; UNITED STATES;

EID: 33750320955     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/505947     Document Type: Article

References (19)

1. Witte JJ, Karchmer AW, Case G, et al. Epidemiology of rubella. Am J Dis Child 1969; 118:107-11.
2. Williams NM, Preblud SR. Rubella and congenital rubella surveillance, 1983. MMWR CDC Surveill Summ 1984; 33:1SS-10SS.
3. Reef SE, Frey TK, Theall K, et al. The changing epidemiology of rubella in the 1990s: on the verge of elimination and new challenges for control and prevention. JAMA 2002; 287:464-72.
4. Groseclose SL, Brathwaite WS, Hall PA, et al. Summary of notifiable diseases-United States, 2002. MMWR Morb Mortal Wkly Rep 2004; 51:1-84.
5. Hethcote HW. Measles and rubella in the United States. Am J Epidemiol 1983; 117:2-13.
6. Herrera GA, Smith P, Daniels D, et al. National, state, and urban area vaccination coverage levels among children aged 19-35 months-United States, 1998. MMWR CDC Surveill Summ 2000; 49:1-26.
7. National, state, and urban area vaccination coverage among children aged 19-35 months-United States, 2003. MMWR Morb Mortal Wkly Rep 2004; 53:658-61.
8. Centers for Disease Control and Prevention. Vaccination coverage among children enrolled in Head Start programs, licensed child care facilities, and entering school-United States, 2000-01 school year. MMWR Morb Mortal Wkly Rep 2003; 52:175-80.
9. Centers for Disease Control and Prevention. Vaccination coverage among children entering school-United States, 2003-04 school year. MMWR Morb Mortal Wkly Rep 2004; 53:1041-4.
10. Reef SE, Redd SB, Abernathy E, Zimmerman L, Icenogle J. The epidemiological profile of rubella and congenital rubella syndrome in the United States, 1998-2004: the evidence for absence of endemic transmission. Clin Infect Dis 2006; 43:S126-32 (in this supplement).
11. Dykewicz CA, Kruszon-Moran D, McQuillan GM, et al. Rubella seropositivity in the United States, 1988-1994. Clin Infect Dis 2001; 33: 1279-86.
12. Gunter EW, McQuillan G. Quality control in planning and operating the laboratory component for the Third National Health and Nutrition Examination Survey. J Nutr 1990; 120(Suppl II):1451-4.
13. Shah BV, Barnwell BG, Bieler GS, La Vange LM. SUDAAN software for the statistical analysis of correlated data, user's manual release 7.0. Cary, North Carolina: Research Triangle Institute, 1996.
14. Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol 2001; 154:357-65.
15. Forghani B, Schmidt NJ. Antigen requirements, sensitivity, and specificity of enzyme immunoassays for measles and rubella viral antibodies. J Clin Microbiol 1979; 9:657-64.
16. Collett D. Binary modeling. London: Chapman and Hall, 1991.
17. Kilgore PE, Kruszon-Moran D, Seward JF, et al. Varicella in Americans from NHANES III: implications for control through routine immunization. J Med Virol 2003;70(Suppl 1):S111-8.
18. Dayan GH, Castillo-Solórzano C, Nava M, et al. Efforts at rubella elimination in the United States: the impact of hemispheric rubella control. Clin Infect Dis 2006; 43:S158-63 (in this supplement).
19. Bloom S, Smith P, Stanwyck C, Stokley S. Has the United States population been adequately vaccinated to achieve rubella elimination? Clin Infect Dis 2006; 43:S141-5 (in this supplement).